Abstract:KEY POINTS:Smooth muscle myosin regulatory light chain (RLC) is phosphorylated by Ca2+ /calmodulin-dependent myosin light chain kinase and dephosphorylated by myosin light chain phosphatase (MLCP). Tracheal smooth muscle contains significant amounts of myosin binding subunit 85 (MBS85), another myosin phosphatase targeting subunit (MYPT) family member, in addition to MLCP regulatory subunit MYPT1. Concentration/temporal responses to carbachol demonstrated similar sensitivities for bovine tracheal force development and phosphorylation of RLC, MYPT1, MBS85 and paxillin. Electrical field stimulation releases ACh from nerves to increase RLC phosphorylation but not MYPT1 or MBS85 phosphorylation. Thus, nerve-mediated muscarinic responses in signalling modules acting on RLC phosphorylation are different from pharmacological responses with bath added agonist. The conditional knockout of MYPT1 or the knock-in mutation T853A in mice had no effect on muscarinic force responses in isolated tracheal tissues. MLCP activity may arise from functionally shared roles between MYPT1 and MBS85, resulting in minimal effects of MYPT1 knockout on contraction.ABSTRACT:Ca2+ /calmodulin activation of myosin light chain kinase (MLCK) initiates myosin regulatory light chain (RLC) phosphorylation for smooth muscle contraction with subsequent dephosphorylation for relaxation by myosin light chain phosphatase (MLCP) containing regulatory (MYPT1) and catalytic (PP1cδ) subunits. RLC phosphorylation-dependent force development is regulated by distinct signalling modules involving protein phosphorylations. We investigated responses to cholinergic agonist treatment vs. neurostimulation by electric field stimulation (EFS) in bovine tracheal smooth muscle. Concentration/temporal responses to carbachol demonstrated tight coupling between force development and RLC phosphorylation but sensitivity differences in MLCK, MYPT1 T853, MYPT1 T696, myosin binding subunit 85 (MBS85), paxillin and CPI-17 (PKC-potentiated protein phosphatase 1 inhibitor protein of 17 kDa) phosphorylations. EFS increased force and phosphorylation of RLC, CPI-17 and MLCK. In the presence of the cholinesterase inhibitor neostigmine, EFS led to an additional increase in phosphorylation of MYPT1 T853, MYPT1 T696, MBS85 and paxillin. Thus, there were distinct pharmacological vs. physiological responses in signalling modules acting on RLC phosphorylation and force responses, probably related to degenerate G protein signalling networks. Studies with genetically modified mice were performed. Expression of another MYPT1 family member, MBS85, was enriched in mouse, as well as bovine tracheal smooth muscle. Carbachol concentration/temporal-force responses were similar in trachea from MYPT1SM+/+ , MYPT1SM-/- and the knock-in mutant mice containing nonphosphorylatable MYPT1 T853A with no differences in RLC phosphorylation. Thus, MYPT1 T853 phosphorylation was not necessary for regulation of RLC phosphorylation in tonic airway smooth muscle. Furthermore, MLCP activity may arise from functionally shared roles between MYPT1 and MBS85, resulting in minimal effects of MYPT1 knockout on contraction.

Understanding Signaling Regulation of Gut Smooth Muscle Contraction from Genetics Evidence

Myosin Light Chain Kinase is Central to Smooth Muscle Contraction and Required for Gastrointestinal Motility in Mice

Altered Contractile Phenotypes of Intestinal Smooth Muscle in Mice Deficient in Myosin Phosphatase Target Subunit 1

The Long Noncoding RNA Cardiac Mesoderm Enhancer- Associated Noncoding RNA (carmn) is a Critical Regulator of Gastrointestinal Smooth Muscle Contractile Function and Motility

Physiological Signalling to Myosin Phosphatase Targeting Subunit‐1 Phosphorylation in Ileal Smooth Muscle

Mlck Deletion Enhances Intestinal Smooth Muscle Cells Migration by Reducing Cell Membrane Tension

Signaling Through Myosin Light Chain Kinase in Smooth Muscles.

Abstract 3142: Pik3c3 Safeguards Smooth Muscle Identity by Promoting Lysosome-mediated Yap1 Degradation

Agonist-induced Ca 2 +-sensitization in smooth muscle : redundancy of RhoGEFs and response kinetics ; a caged compound study

Molecular and Cellular Basis of the Regulation of Lymphatic Contractility and Lymphatic Absorption.

p90RSK2, a new MLCK mediates contractility in myosin light chain kinase null smooth muscle

Structure-activity and immunochemical data provide evidence of developmental- and tissue-specific myosuppressin signaling

Kindlin-2 deficiency induces fatal intestinal obstruction in mice

p90RSK2, a new MLCK, rescues contractility in myosin light chain kinase null smooth muscle

Characterization of in Vivo Function of Myosin Light Chain Kinase in Internal Anal Sphincter Contraction

Persistent mechanical stretch-induced calcium overload and MAPK signal activation contributed to SCF reduction in colonic smooth muscle in vivo and in vitro

SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy

Mechanisms underlying distinct subcellular localization and regulation of epithelial long myosin light-chain kinase splice variants

C-Abl Regulates Gastrointestinal Muscularis Propria Homeostasis Via ERKs

In Vivo Roles for Myosin Phosphatase Targeting Subunit-1 Phosphorylation Sites T694 and T852 in Bladder Smooth Muscle Contraction.

Physiological Vs. Pharmacological Signalling to Myosin Phosphorylation in Airway Smooth Muscle